BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29

• Drug Development

  Cylene Pharmaceuticals, Inc. to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at Biotechnology Industry Organization (BIO) Conference

  May 19, 2009

   · 

  1 min read
• Drug Development

  ChemoCentryx, Inc.'s Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn’s Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week

  May 19, 2009

   · 

  6 min read
• Business

  Mercury Therapeutics, Inc. Outlicenses Research Products Applications of AMP-Activated Protein Kinase to Millipore Corporation

  May 19, 2009

   · 

  1 min read
• Drug Development

  IntelGenx Corp. And Circ Pharma Ltd to Commence Phase 1 Proof-of-Concept Study of CRES Pravastatin, a Novel Low Dose Formulation Containing Pravastatin for the Treatment of Hyperlipidemia

  May 19, 2009

   · 

  4 min read
• BioForest

  Dragon Pharmaceuticals Inc. Announces June 21, 2009 for 2009 Annual Shareholders’ Meeting

  May 19, 2009

   · 

  1 min read
• BioMidwest

  AVI BioPharma, Inc. to Present at TIDES 2009 Conference

  May 19, 2009

   · 

  2 min read
• Biotech Bay

  Bio-Rad Laboratories, Inc. Announces Private Offering of $250 Million of Senior Subordinated Notes

  May 19, 2009

   · 

  2 min read
• Business

  Trimedyne, Inc. Reports Its Financial Results for the Quarter Ended March 31, 2009

  May 19, 2009

   · 

  8 min read
• Lone Star Bio

  Metiscan, Inc. Considers Becoming Apple iPhone Developer

  May 19, 2009

   · 

  3 min read
• Business

  International Isotopes Announces First Quarter 2009 Financial Results

  May 19, 2009

   · 

  5 min read